Thomas C. Merigan
- Infectious Diseases top 0.1%
- Virology top 0.05%
- Epidemiology top 0.2%
- Immunology top 0.5%
- Oncology top 1%
- Co-authors
- Richard B. PollardMark A. WintersMartin HirschTeresa Y. BashamKenneth H. RandDavid KatzensteinWilliam H. RobinsonRichard C. Reichman
- Topics
- HIV Research and Treatment (71 papers)HIV/AIDS drug development and treatment (60 papers)HIV/AIDS Research and Interventions (45 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Thomas C. Merigan
230 papers receiving 13.5k citations
Hit Papers
Peers
Comparison fields: 5 of 180
- Infectious Diseases 6.0k
- Virology 5.2k
- Epidemiology 5.2k
- Immunology 3.3k
- Oncology 1.7k
Countries citing papers authored by Thomas C. Merigan
This map shows the geographic impact of Thomas C. Merigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas C. Merigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas C. Merigan more than expected).
Fields of papers citing papers by Thomas C. Merigan
This network shows the impact of papers produced by Thomas C. Merigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas C. Merigan. The network helps show where Thomas C. Merigan may publish in the future.
Co-authorship network of co-authors of Thomas C. Merigan
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas C. Merigan. A scholar is included among the top collaborators of Thomas C. Merigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas C. Merigan. Thomas C. Merigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 50 | |
| 2 | 6 | |
| 3 | 19 | |
| 4 | 24 | |
| 5 | 8 | |
| 6 | Antimicrobial therapy and vaccines : editors, Victor L. Yu, Thomas C. Merigan,Jr., Steven L. Barriere ; associate editors, Alan M. Sugar ... [et al.] | 1 |
| 7 | Antiviral agents and human viral diseases. | 36 |
| 8 | 16 | |
| 9 | 8 | |
| 10 | 2 | |
| 11 | 2 | |
| 12 | 7 | |
| 13 | Interferons as cell growth inhibitors and antitumor factors : proceedings of a UCLA Symposium held in Steamboat Springs, Colorado, April 6-12, 1986 | 1 |
| 14 | 4 | |
| 15 | 91 | |
| 16 | 9 | |
| 17 | 29 | |
| 18 | 11 | |
| 19 | 46 | |
| 20 | 12 |
About Thomas C. Merigan
Thomas C. Merigan is a scholar working on Virology, Infectious Diseases and Immunology, having authored 234 papers that have together received 15.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (71 papers), HIV/AIDS drug development and treatment (60 papers) and HIV/AIDS Research and Interventions (45 papers). The work is most often cited by research in Virology (5.2k citations), Infectious Diseases (6.0k citations) and Immunology (3.3k citations). Thomas C. Merigan has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Richard B. Pollard, Mark A. Winters, Martin Hirsch, Teresa Y. Basham, Kenneth H. Rand, David Katzenstein, William H. Robinson, Richard C. Reichman, Vera B. Morhenn and George W. Jordan. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.